Listen Score
LS 27
Global Rank
TOP 10%

ÜBER DIESEN PODCAST 🔗

Aktualisierungshäufigkeit:
semiweekly
Durchschnittliche Audiolänge:
33 minutes
Hat Sponsoren
Englisch
Vereinigte Staaten
633 Folgen
seit 28. Juni 2019
episodic

AUDIENCE OF THIS PODCAST 🔗

~64.60% of listeners are from India.
🇮🇳
IN
64.60%
🇺🇸
US
28.35%
🇩🇪
DE
1.70%
🇦🇺
AU
1.27%
🇦🇷
AR
0.63%
🇨🇦
CA
0.63%
🇬🇧
GB
0.42%
🇦🇪
AE
0.42%
🇵🇭
PH
0.42%
🇩🇰
DK
0.21%
🇪🇬
EG
0.21%
🇹🇿
TZ
0.21%
🇹🇼
TW
0.21%
🇸🇦
SA
0.21%
🇨🇱
CL
0.21%
🇩🇿
DZ
0.21%
Others
0.09%
* Data source: directly measured on Listen Notes. in Echtzeit

NEUESTE FOLGEN 🔗

Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarti…

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Keeping Current durchsuchen.

FRÜHERE EPISODEN

A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-20…
Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-ne…
ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therap…
Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podca…
Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_…
Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outco…
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more. Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-…
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases? Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1…
Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Medscape Podcasts, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.